← Eichor
Study identifier: NCT06051227 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial

Condition: Acute Pain Due to Trauma · Analgesia · Fentanyl  ·  Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

PhasePhase 3
Planned participants608
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Fentanyl and esketamine are both standard of care for treatment of acute severe traumatic pain in the prehospital setting in the Netherlands. However, it is not known whether they are equally effective and safe. It is also not known whether intranasal (IN) administration of fentanyl or esketamine is equally effective and safe as intravenous (IV) administration. The FORE-PAIN trial is a double-blind multi-arm randomized non-inferiority trial comparing Fentanyl IN, esketamine IV and esketamine IN (intervention arms) to fentanyl IV (comparator arm) for prehospital management of traumatic pain. The investigators hypothesize that all intervention arms provide analgesia that is non-inferior to the comparator arm, and that all study arms are equally safe.

This description comes directly from the study's public registry record.

Talk to the study team

Robert P Weenink, PhD  ·  +31 205669111  ·  forepain@amsterdamumc.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Ambulance AmsterdamAmsterdam, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06051227